Brief: TaiMed Biologics Says In Deal With Samsung Biologics Regarding Product TMB-365
BRIEF-TaiMed Biologics Says In Deal With Samsung Biologics Regarding Product TMB-365 June 22 (Reuters) - TaiMed Biologics 4147.TWO:
SAYS IN DEAL WITH SAMSUNG BIOLOGICS 207940.KS REGARDING PRODUCT TMB-365
Source text: ID:nMOP9YB8ch
Further company coverage: 4147.TWO
(Reporting by Hong Kong newsroom)
((donny.kwok@thomsonreuters.com; +852 3462 7745;))
Recent news on Samsung Biologics Co
See all newsSouth Korean shares fall more than 4% on profit-taking
Brief: TaiMed Biologics Says In Deal With Samsung Biologics Regarding Product TMB-365
South Korean shares end lower on Middle East uncertainty
South Korean shares turn lower on fresh Mideast uncertainty
South Korea's KOSPI index tops 9,000 as chipmakers hit records